FDA takes action against Abbvie for misleading Ubrelvy ad with Serena Williams
The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena Williams.
FDA slams AbbVie for misleading claims in Serena Williams ad for migraine drug Ubrelvy
The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena Williams that went out of bounds with claims about how quickly the product relieves symptoms.
AbbVie faulted for misleading ad featuring Serena Williams
In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk show dressing room, which resolves by the time she walks onto the set and allows her to carry out the interview laughing and pain-free.
FDA sends letter to drugmaker, says ad featuring Serena Williams was misleading
A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure migraine headaches.
FDA scolds AbbVie over ‘misleading’ TV ad for a migraine pill featuring Serena Williams
The FDA has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena Williams.
'Aint She Rich Enuf?': Serena Williams Under Fire as the FDA Steps In Following 'Misleading' Commercial for Migraine Medicine Maker
ScienceAlert50m
Expensive Migraine Drugs No Better Than Cheap Painkillers, Study Finds
The newer and more expensive drugs rimegepant and ubrogepant — as well as another called lasmiditan, which can have drowsy ...
JD Supra1d
Ubrelvy Untitled Letter – A Double Fault for AbbVie? Or Makeup Misread for FDA?
The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...
FiercePharma9d
AbbVie's Ubrelvy to be top migraine seller in 2033
AbbVie’s migraine drug Ubrelvy (ubrogepant) is slated to be the top-selling drug in the migraine space in 2033 across the ...
Migraine Drug Ubrelvy May Stop Headaches Even Before They Start
A migraine drug can stop the devastating headache symptoms of migraines in their tracks, allowing sufferers to go about their ...
Inquirer on MSN15h
New migraine drugs no better than cheap painkillers – big study
New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...